# Effects of Catheter Ablation on Burden of Atrial Fibrillation (MRICEMAN)

Study · id `cardio:ct-nct02639793` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02639793](<https://clinicaltrials.gov/study/NCT02639793>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02639793

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

## Technical summary

Registry record NCT02639793. Randomized; single masking; primary purpose treatment. Start 2016-01 (registry gives no type); primary completion 2019-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT02639793, source copy `cardio:ctgov-nct02639793-2015-12-28`, retrieved 2026-10-26)
- Start date: 2016-01 (registry gives no type) (ClinicalTrials.gov record NCT02639793, source copy `cardio:ctgov-nct02639793-2015-12-28`, retrieved 2026-10-26)
- Primary completion: 2019-12 (anticipated) (ClinicalTrials.gov record NCT02639793, source copy `cardio:ctgov-nct02639793-2015-12-28`, retrieved 2026-10-26)
- Completion: 2020-01 (anticipated) (ClinicalTrials.gov record NCT02639793, source copy `cardio:ctgov-nct02639793-2015-12-28`, retrieved 2026-10-26)
- Countries: Finland (ClinicalTrials.gov record NCT02639793, source copy `cardio:ctgov-nct02639793-2015-12-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02639793-2015-12-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effects of Catheter Ablation on Burden of Atrial Fibrillation (MRICEMAN)
- Acronym: MRICEMAN
- Condition: Atrial Fibrillation
- Intervention (Procedure): catheter ablation
- Lead sponsor: Heikki Huikuri
- Lead sponsor class: OTHER
- Collaborator: University of Helsinki
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as a collaborator: University of Helsinki (`cardio:org-university-of-helsinki`)

## Provenance

Content hash: 94b45f6e660a625f115c56d99be49b5022f7be4a0c4195627ac12048dde60909
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
